Institution identification

Institution ID

15887

Institution full name and acronym

Pharmacoepidemiology and Drug Safety Research Group (PharmaSafe), University of Oslo

Institution countries

Norway

Type of institution

Educational Institution

Institution website

ENCePP partner

Yes
Institution description
The PharmacoEpidemiology & Drug Safety Research Group covers a wide range of research activities related to optimal use and safety of medication on an individual and societal level. We use epidemiological methods to address questions of drug safety that cannot be studies in randomized controlled trials (RCTs). Our work includes monitoring of drug utilization in pregnancy,perception towards medicines,methodology research,analysis of medication safety on patient outcomes and health economics.The research group is multidiciplinary and has expertise in pharmacoepidemiology and drug safety,biostatistics,mathematics,health economics and pharmacOtherapy.
Institution details
Experience with collecting data directly from individual patients or respondents:
Yes
Interest in carrying out research that is funded by pharmaceutical companies:
No

Contact

Studies conducted by the institution

ADEPT: feasibility of estimating the risk of adverse pregnancy, neonatal and child outcomes following either in utero ASM exposure through the mother, or peri-conceptional ASM exposure through the father
ADEPT: The utilisation of antiseizure medications in pregnant women, other women of childbearing potential, and men: a multi-database study from 7 European countries
Antipsychotics in pregnancy and the risk of adverse pregnancy outcomes - a nationwide study
CONSIGN study: COVID-19 infection and medicines in pregnancy - a multinational registry based study
Demonstrating solutions for studying intermittent medication exposures in diseases with episodic manifestations during pregnancy: application to medication for migraine in pregnancy
Levocetirizine/cetirizine levels in human milk – an observational, clinical study among breastfeeding women
Methods for controlling by indication for prescriptions: application to medications for neuropathic pain
Novel statistics to handle rare diseases and small sample sizes using Bayesian techniques: Application to Multiple Sclerosis (MS) and Systemic Lupus Erythematosus (SLE) in pregnancy
Paternal exposure to valproate and the risk of neurodevelopmental disorders in children
Studying drug exposure when disease is measured through accurate identification of an incident case: application to breast cancer in pregnancy (ConcePTION breast cancer demo)
The PRIDE-Asthma cohort: insight into the short- and long-term effects of asthma and asthma medication during pregnancy